Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$535M |
| 2 |
Meta Platforms (Facebook)
META
|
+$388M |
| 3 |
SLB Ltd
SLB
|
+$348M |
| 4 |
Visa
V
|
+$230M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$203M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$350M |
| 2 |
Chevron
CVX
|
+$349M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$337M |
| 4 |
Dell
DELL
|
+$332M |
| 5 |
SODA
SodaStream International Ltd
SODA
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.48% |
| 2 | Technology | 13.21% |
| 3 | Financials | 10.74% |
| 4 | Real Estate | 9.97% |
| 5 | Utilities | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Knowles
KN
$3.13B
| $3.62M | ﹤0.01% |
271,774
+72,796
| +37% | +$1.07M |
|
1927
Harrow
HROW
$1.45B
| $3.62M | ﹤0.01% |
635,316
+542,200
| +582% | +$2.32M |
|
1928
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
| $3.62M | ﹤0.01% |
+34,300
| New | +$3.59M |
|
1929
CareDx
CDNA
$2.26B
| $3.61M | ﹤0.01% |
143,600
+48,900
| +52% | +$1.26M |
|
1930
First Business Financial Services
FBIZ
$587M
| $3.61M | ﹤0.01% |
184,900
-23,700
| -11% | -$491K |
|
1931
Magnite
MGNI
$2.76B
| $3.6M | ﹤0.01% |
966,604
+390,709
| +68% | +$1.49M |
|
|
GEN
1932
DELISTED
Genesis Healthcare, Inc.
GEN
| $3.6M | ﹤0.01% |
3,053,411
+157,800
| +5% | +$234K |
|
|
WIN
1933
DELISTED
Windstream Holdings Inc
WIN
| $3.6M | ﹤0.01% |
1,723,408
-54,600
| -3% | -$203K |
|
|
ADAP
1934
DELISTED
Adaptimmune Therapeutics
ADAP
| $3.6M | ﹤0.01% |
626,300
-407,500
| -39% | -$3.01M |
|
1935
Friedman Industries
FRD
$240M
| $3.6M | ﹤0.01% |
510,120
-44,105
| -8% | -$367K |
|
1936
TG Therapeutics
TGTX
$7.96B
| $3.59M | ﹤0.01% |
875,900
+523,400
| +148% | +$2.6M |
|
1937
Adeia
ADEA
$2.94B
| $3.59M | ﹤0.01% |
737,856
-757,890
| -51% | -$2.95M |
|
1938
Air T
AIRT
$75.5M
| $3.58M | ﹤0.01% |
219,212
+2,550
| +1% | +$56.3K |
|
1939
Axcelis
ACLS
$4.01B
| $3.58M | ﹤0.01% |
200,899
-28,800
| -13% | -$512K |
|
1940
James Hardie Industries
JHX
$15.3B
| $3.57M | ﹤0.01% |
304,227
+6,900
| +2% | +$85.7K |
|
1941
Hecla Mining
HL
$9.47B
| $3.57M | ﹤0.01% |
1,513,190
+1,147,900
| +314% | +$2.94M |
|
1942
Nordson
NDSN
$16.6B
| $3.57M | ﹤0.01% |
+29,909
| New | +$3.67M |
|
1943
Xenon Pharmaceuticals
XENE
$6.06B
| $3.57M | ﹤0.01% |
565,700
+38,363
| +7% | +$341K |
|
|
PSXP
1944
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $3.56M | ﹤0.01% |
84,600
+76,204
| +908% | +$3.69M |
|
1945
DHI Group
DHX
$182M
| $3.55M | ﹤0.01% |
2,336,000
+62,700
| +3% | +$108K |
|
|
ACRE
1946
Ares Commercial Real Estate
ACRE
$236M
| $3.55M | ﹤0.01% |
272,200
+99,700
| +58% | +$1.39M |
|
1947
Enviri
NVRI
$623M
| $3.55M | ﹤0.01% |
178,600
+34,800
| +24% | +$863K |
|
|
KALV
1948
DELISTED
KalVista Pharmaceuticals
KALV
| $3.54M | ﹤0.01% |
179,229
+61,880
| +53% | +$1.24M |
|
1949
First Bancorp
FBP
$4.42B
| $3.53M | ﹤0.01% |
410,500
-547,142
| -57% | -$4.89M |
|
1950
MakeMyTrip
MMYT
$5.36B
| $3.52M | ﹤0.01% |
144,853
+55,898
| +63% | +$1.34M |
|
Similar funds
Renaissance Technologies's Q4 2018 Portfolio in Review
As of Q4 2018, Renaissance Technologies held 3,847 positions worth $91.3B, down 6.1% from $97.3B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies deployed $8.84B of net new capital in Q4 2018, opening 522 new positions and adding to 1,588 existing holdings. Its largest new stake was Apple: 11,041,936 shares worth $435M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Dell, an estimated $332M trimmed.
- Renaissance Technologies's largest Q4 2018 buy was Apple: 11,041,936 shares worth $435M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2018, an estimated $388M increase.
- Renaissance Technologies's biggest Q4 2018 reduction was Dell, cutting an estimated $332M.
- Renaissance Technologies fully exited Danaher in Q4 2018, selling an estimated $350M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $91.3B portfolio in Q4 2018.
- Renaissance Technologies opened 522 new positions and closed 504 in Q4 2018.
- Renaissance Technologies's portfolio value fell 6.1% quarter-over-quarter to $91.3B.
Based on Renaissance Technologies's 13F filing for Q4 2018, filed 13 Feb 2019.